Zhou Yu-Ping について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wei Yun-Peng について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Yang Yin-Jian について
Department of Medical Science Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Xu Xi-Qi について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Liu Chao について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Mei Ke-Yi について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Peng Fu-Hua について
Department of Pulmonary Vascular Disease and Thrombosis Medicine, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wang Hai-Ping について
Department of Radiology, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Sun Kai について
Department of Medical Science Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Li Jing-Yi について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wang Hui-Fang について
Department of Medical Laboratory, Weifang Medical University, Weifang, Shandong, China について
Li Meng-Tao について
Department of Rheumatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Scien... について
Wang Duo-Lao について
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom について
Miao Qi について
Department of Cardiovascular Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Jiang Xin について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Jing Zhi-Cheng について
Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Journal of the American College of Cardiology について
死 について
生存率 について
治療法 について
回帰モデル について
合併症 について
肺高血圧症 について
大動脈炎症候群 について
血栓塞栓症 について
血管形成術 について
コホート研究 について
3年生存率 について
NPPV について
肺血管 について
慢性血栓塞栓性肺高血圧症 について
リスク低減 について
治療法選択 について
総死亡率 について
有効性 について
経皮的肺動脈形成術 について
肺高血圧症 について
安全 について
高安動脈炎 について
循環系疾患の外科療法 について
循環系疾患の治療一般 について
高安動脈炎 について
肺高血圧症 について
患者 について
肺 について
血管形成術 について